{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T11:19:48Z","timestamp":1740136788064,"version":"3.37.3"},"reference-count":61,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1124\/jpet.122.001354","type":"journal-article","created":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T12:55:14Z","timestamp":1662123314000},"page":"157-171","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Differential Activation and Desensitization States Promoted by Noncanonical \u03b1 7 Nicotinic Acetylcholine Receptor Agonists"],"prefix":"10.1016","volume":"383","author":[{"given":"Clare","family":"Stokes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gisela Andrea","family":"Camacho-Hernandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ganesh A.","family":"Thakur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoxuan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Palmer","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4468-8658","authenticated-orcid":false,"given":"Roger L.","family":"Papke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.122.001354_bib1","doi-asserted-by":"crossref","first-page":"726","DOI":"10.2105\/AJPH.86.5.726","article-title":"Adjusting for multiple testing when reporting research results: the Bonferroni vs Holm methods","volume":"86","author":"Aickin","year":"1996","journal-title":"Am J Public Health"},{"key":"10.1124\/jpet.122.001354_bib2","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/S0026-895X(25)09068-6","article-title":"Blockade of nicotinic currents in hippocampal neurons defines methyllycaconitine as a potent and specific receptor antagonist","volume":"41","author":"Alkondon","year":"1992","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.122.001354_bib3","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.neuropharm.2016.02.032","article-title":"Exploring the positive allosteric modulation of human \u03b17 nicotinic receptors from a single-channel perspective","volume":"107","author":"Andersen","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1124\/jpet.122.001354_bib4","doi-asserted-by":"crossref","first-page":"415","DOI":"10.2174\/1570159X15666170818102108","article-title":"New Insights on Neuronal Nicotinic Acetylcholine Receptors as Targets for Pain and Inflammation: A Focus on \u03b17 nAChRs","volume":"16","author":"Bagdas","year":"2018","journal-title":"Curr Neuropharmacol"},{"key":"10.1124\/jpet.122.001354_bib5","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/228917a0","article-title":"Structure and activity of acetylcholine","volume":"228","author":"Beers","year":"1970","journal-title":"Nature"},{"key":"10.1124\/jpet.122.001354_bib6","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1124\/pr.113.008581","article-title":"Therapeutic Potential of \u03b17 Nicotinic Acetylcholine Receptors","volume":"67","author":"Bertrand","year":"2015","journal-title":"Pharmacol Rev"},{"key":"10.1124\/jpet.122.001354_bib7","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1021\/jm049363q","article-title":"Discovery and structure-activity relationship of quinuclidine benzamides as agonists of alpha7 nicotinic acetylcholine receptors","volume":"48","author":"Bodnar","year":"2005","journal-title":"J Med Chem"},{"key":"10.1124\/jpet.122.001354_bib8","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1113\/JP275101","article-title":"Molecular function of \u03b17 nicotinic receptors as drug targets","volume":"596","author":"Bouzat","year":"2018","journal-title":"J Physiol"},{"key":"10.1124\/jpet.122.001354_bib9","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/35077011","article-title":"Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors","volume":"411","author":"Brejc","year":"2001","journal-title":"Nature"},{"key":"10.1124\/jpet.122.001354_bib10","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1111\/j.1476-5381.2009.00426.x","article-title":"Role of channel activation in cognitive enhancement mediated by alpha7 nicotinic acetylcholine receptors","volume":"158","author":"Briggs","year":"2009","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.122.001354_bib11","doi-asserted-by":"crossref","first-page":"10376","DOI":"10.1021\/acs.jmedchem.9b01467","article-title":"Synthesis, Pharmacological Characterization, and Structure-Activity Relationships of Noncanonical Selective Agonists for \u03b17 nAChRs","volume":"62","author":"Camacho-Hernandez","year":"2019","journal-title":"J Med Chem"},{"key":"10.1124\/jpet.122.001354_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108108","article-title":"Lessons from nature: Structural studies and drug design driven by a homologous surrogate from invertebrates, AChBP","volume":"179","author":"Camacho-Hernandez","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1124\/jpet.122.001354_bib13","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/sj.bjp.0707264","article-title":"The alpha7 nicotinic acetylcholine receptor as a pharmacological target for inflammation","volume":"151","author":"de Jonge","year":"2007","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.122.001354_bib14","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1124\/mol.111.076026","article-title":"A series of \u03b17 nicotinic acetylcholine receptor allosteric modulators with close chemical similarity but diverse pharmacological properties","volume":"81","author":"Gill","year":"2012","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.122.001354_bib15","doi-asserted-by":"crossref","first-page":"5867","DOI":"10.1073\/pnas.1017975108","article-title":"Agonist activation of alpha7 nicotinic acetylcholine receptors via an allosteric transmembrane site","volume":"108","author":"Gill","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.122.001354_bib16","doi-asserted-by":"crossref","first-page":"841","DOI":"10.2174\/1389557520666200130105256","article-title":"In Silico Modeling of the \u03b17 Nicotinic Acetylcholine Receptor: New Pharmacological Challenges Associated with Multiple Modes of Signaling","volume":"20","author":"Gulsevin","year":"2020","journal-title":"Mini Rev Med Chem"},{"key":"10.1124\/jpet.122.001354_bib17","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1124\/mol.119.115758","article-title":"Allosteric Agonism of \u03b1 7 Nicotinic Acetylcholine Receptors: Receptor Modulation Outside the Orthosteric Site","volume":"95","author":"Gulsevin","year":"2019","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.122.001354_bib18","doi-asserted-by":"crossref","first-page":"34411","DOI":"10.1074\/jbc.M300170200","article-title":"Conservation within the RIC-3 gene family. Effectors of mammalian nicotinic acetylcholine receptor expression","volume":"278","author":"Halevi","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.122.001354_bib19","doi-asserted-by":"crossref","first-page":"3040","DOI":"10.1038\/emboj.2009.227","article-title":"Structural determinants for interaction of partial agonists with acetylcholine binding protein and neuronal alpha7 nicotinic acetylcholine receptor","volume":"28","author":"Hibbs","year":"2009","journal-title":"EMBO J"},{"key":"10.1124\/jpet.122.001354_bib20","doi-asserted-by":"crossref","first-page":"4396","DOI":"10.1523\/JNEUROSCI.5269-04.2005","article-title":"A novel positive allosteric modulator of the alpha7 neuronal nicotinic acetylcholine receptor: in vitro and in vivo characterization","volume":"25","author":"Hurst","year":"2005","journal-title":"J Neurosci"},{"key":"10.1124\/jpet.122.001354_bib21","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1046\/j.1471-4159.2003.01578.x","article-title":"Nicotine trapping causes the persistent desensitization of alpha4beta2 nicotinic receptors expressed in oocytes","volume":"84","author":"Jia","year":"2003","journal-title":"J Neurochem"},{"key":"10.1124\/jpet.122.001354_bib22","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0166-2236(99)01471-X","article-title":"Nicotinic receptors in the brain: correlating physiology with function","volume":"22","author":"Jones","year":"1999","journal-title":"Trends Neurosci"},{"key":"10.1124\/jpet.122.001354_bib23","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.tips.2018.01.002","article-title":"Beyond the Channel: Metabotropic Signaling by Nicotinic Receptors","volume":"39","author":"Kabbani","year":"2018","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/jpet.122.001354_bib24","doi-asserted-by":"crossref","first-page":"3676","DOI":"10.1021\/jacs.6b10746","article-title":"Substituted 2-Aminopyrimidines Selective for \u03b17-Nicotinic Acetylcholine Receptor Activation and Association with Acetylcholine Binding Proteins","volume":"139","author":"Kaczanowska","year":"2017","journal-title":"J Am Chem Soc"},{"key":"10.1124\/jpet.122.001354_bib25","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1113\/jphysiol.1957.sp005838","article-title":"A study of the desensitization produced by acetylcholine at the motor end-plate","volume":"138","author":"Katz","year":"1957","journal-title":"J Physiol"},{"key":"10.1124\/jpet.122.001354_bib26","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1002\/2211-5463.12270","article-title":"A G protein-coupled \u03b17 nicotinic receptor regulates signaling and TNF-\u03b1 release in microglia","volume":"7","author":"King","year":"2017","journal-title":"FEBS Open Bio"},{"key":"10.1124\/jpet.122.001354_bib27","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1124\/mol.117.111401","article-title":"Ionotropic and Metabotropic Mechanisms of Allosteric Modulation of \u03b1 7 Nicotinic Receptor Intracellular Calcium","volume":"93","author":"King","year":"2018","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.122.001354_bib28","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/00008877-199911000-00014","article-title":"AR-R17779, and alpha7 nicotinic agonist, improves learning and memory in rats","volume":"10","author":"Levin","year":"1999","journal-title":"Behav Pharmacol"},{"key":"10.1124\/jpet.122.001354_bib29","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1038\/npp.2017.276","article-title":"Bidirectional Regulation of Aggression in Mice by Hippocampal Alpha-7 Nicotinic Acetylcholine Receptors","volume":"43","author":"Lewis","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/jpet.122.001354_bib30","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1124\/molpharm.120.000012","article-title":"Allosterically Potentiated \u03b1 7 Nicotinic Acetylcholine Receptors: Reduced Calcium Permeability and Current-Independent Control of Intracellular Calcium","volume":"98","author":"Miller","year":"2020","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.122.001354_bib31","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1111\/bph.13769","article-title":"Hippocampal \u03b17 nicotinic ACh receptors contribute to modulation of depression-like behaviour in C57BL\/6J mice","volume":"175","author":"Mineur","year":"2018","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.122.001354_bib32","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1016\/j.cell.2021.02.049","article-title":"Structure and gating mechanism of the \u03b17 nicotinic acetylcholine receptor","volume":"184","author":"Noviello","year":"2021","journal-title":"Cell"},{"key":"10.1124\/jpet.122.001354_bib33","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s12031-009-9261-0","article-title":"Tricks of perspective: insights and limitations to the study of macroscopic currents for the analysis of nAChR activation and desensitization","volume":"40","author":"Papke","year":"2010","journal-title":"J Mol Neurosci"},{"key":"10.1124\/jpet.122.001354_bib34","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.neuropharm.2014.12.002","article-title":"The analgesic-like properties of the alpha7 nAChR silent agonist NS6740 is associated with non-conducting conformations of the receptor","volume":"91","author":"Papke","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1124\/jpet.122.001354_bib35","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1124\/mol.120.119958","article-title":"Differing Activity Profiles of the Stereoisomers of 2,3,5,6TMP-TQS, a Putative Silent Allosteric Modulator of \u03b1 7 nAChR","volume":"98","author":"Papke","year":"2020","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.122.001354_bib36","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1124\/pharmrev.120.000097","article-title":"Therapeutic Targeting of \u03b1 7 Nicotinic Acetylcholine Receptors","volume":"73","author":"Papke","year":"2021","journal-title":"Pharmacol Rev"},{"key":"10.1124\/jpet.122.001354_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108021","article-title":"Nicotinic acetylcholine receptors: Conventional and unconventional ligands and signaling","volume":"168","author":"Papke","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1124\/jpet.122.001354_bib38","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/sj.bjp.0704833","article-title":"Comparative pharmacology of rat and human alpha7 nAChR conducted with net charge analysis","volume":"137","author":"Papke","year":"2002","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.122.001354_bib39","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ymeth.2010.01.012","article-title":"Working with OpusXpress: methods for high volume oocyte experiments","volume":"51","author":"Papke","year":"2010","journal-title":"Methods"},{"key":"10.1124\/jpet.122.001354_bib40","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.neuropharm.2010.07.014","article-title":"Cysteine accessibility analysis of the human alpha7 nicotinic acetylcholine receptor ligand-binding domain identifies L119 as a gatekeeper","volume":"60","author":"Papke","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1124\/jpet.122.001354_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2017.04.024","article-title":"Effects of BMS-902483, an \u03b17 nicotinic acetylcholine receptor partial agonist, on cognition and sensory gating in relation to receptor occupancy in rodents","volume":"807","author":"Pieschl","year":"2017","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.122.001354_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174179","article-title":"Stable desensitization of \u03b17 nicotinic acetylcholine receptors by NS6740 requires interaction with S36 in the orthosteric agonist binding site","volume":"905","author":"Pismataro","year":"2021","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.122.001354_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112669","article-title":"Design, synthesis, and electrophysiological evaluation of NS6740 derivatives: Exploration of the structure-activity relationship for alpha7 nicotinic acetylcholine receptor silent activation","volume":"205","author":"Pismataro","year":"2020","journal-title":"Eur J Med Chem"},{"key":"10.1124\/jpet.122.001354_bib44","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1124\/jpet.118.249904","article-title":"The Antinociceptive and Anti-Inflammatory Properties of the \u03b1 7 nAChR Weak Partial Agonist p-CF3 N,N-diethyl-N\u2019-phenylpiperazine","volume":"367","author":"Quadri","year":"2018","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.122.001354_bib45","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0026-895X(25)15239-5","article-title":"On the mechanism of desensitization at cholinergic receptors","volume":"6","author":"Rang","year":"1970","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.122.001354_bib46","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0026-895X(25)15240-1","article-title":"The relationship between desensitization and the metaphilic effect at cholinergic receptors","volume":"6","author":"Rang","year":"1970","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.122.001354_bib47","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1523\/JNEUROSCI.13-02-00596.1993","article-title":"Molecular cloning, functional properties, and distribution of rat brain alpha 7: a nicotinic cation channel highly permeable to calcium","volume":"13","author":"S\u00e9gu\u00e9la","year":"1993","journal-title":"J Neurosci"},{"key":"10.1124\/jpet.122.001354_bib48","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1021\/jm00156a005","article-title":"The ensemble approach to distance geometry: application to the nicotinic pharmacophore","volume":"29","author":"Sheridan","year":"1986","journal-title":"J Med Chem"},{"key":"10.1124\/jpet.122.001354_bib49","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.1016\/S0021-9258(18)50761-4","article-title":"Functional consequences of agonist-mediated state transitions in the cholinergic receptor. Studies in cultured muscle cells","volume":"254","author":"Sine","year":"1979","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.122.001354_bib50","doi-asserted-by":"crossref","first-page":"10144","DOI":"10.1016\/S0021-9258(19)70440-2","article-title":"The relationship between agonist occupation and the permeability response of the cholinergic receptor revealed by bound cobra alpha-toxin","volume":"255","author":"Sine","year":"1980","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.122.001354_bib51","doi-asserted-by":"crossref","first-page":"6692","DOI":"10.1016\/S0021-9258(19)69047-2","article-title":"Relationship between reversible antagonist occupancy and the functional capacity of the acetylcholine receptor","volume":"256","author":"Sine","year":"1981","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.122.001354_bib52","first-page":"127","article-title":"Cholinergic channel activators: novel opportunities for the treatment of CNS disorders","volume":"38","author":"Sullivan","year":"1995","journal-title":"Proc West Pharmacol Soc"},{"key":"10.1124\/jpet.122.001354_bib53","doi-asserted-by":"crossref","first-page":"8943","DOI":"10.1021\/jm401267t","volume":"56","author":"Thakur","year":"2013","journal-title":"J Med Chem"},{"key":"10.1124\/jpet.122.001354_bib54","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jneuroim.2012.07.006","article-title":"The \u03b17 nicotinic acetylcholine receptor ligands methyllycaconitine, NS6740 and GTS-21 reduce lipopolysaccharide-induced TNF-\u03b1 release from microglia","volume":"251","author":"Thomsen","year":"2012","journal-title":"J Neuroimmunol"},{"key":"10.1124\/jpet.122.001354_bib55","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1023\/A:1008140021426","article-title":"An improved nicotinic pharmacophore and a stereoselective CoMFA-model for nicotinic agonists acting at the central nicotinic acetylcholine receptors labelled by","volume":"15","author":"T\u00f8nder","year":"2001","journal-title":"J Comput Aided Mol Des"},{"key":"10.1124\/jpet.122.001354_bib56","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1172\/JCI30555","article-title":"Physiology and immunology of the cholinergic antiinflammatory pathway","volume":"117","author":"Tracey","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1124\/jpet.122.001354_bib57","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0006-8993(02)02946-3","article-title":"Activation and inhibition of native neuronal alpha-bungarotoxin-sensitive nicotinic ACh receptors","volume":"948","author":"Uteshev","year":"2002","journal-title":"Brain Res"},{"key":"10.1124\/jpet.122.001354_bib58","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/nature01339","article-title":"Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation","volume":"421","author":"Wang","year":"2003","journal-title":"Nature"},{"key":"10.1124\/jpet.122.001354_bib59","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1124\/mol.112.080317","article-title":"Intrinsically low open probability of \u03b17 nicotinic acetylcholine receptors can be overcome by positive allosteric modulation and serum factors leading to the generation of excitotoxic currents at physiological temperatures","volume":"82","author":"Williams","year":"2012","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.122.001354_bib60","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1124\/mol.111.074302","article-title":"Investigation of the molecular mechanism of the \u03b17 nicotinic acetylcholine receptor positive allosteric modulator PNU-120596 provides evidence for two distinct desensitized states","volume":"80","author":"Williams","year":"2011","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.122.001354_bib61","doi-asserted-by":"crossref","first-page":"14686","DOI":"10.1073\/pnas.0804372105","article-title":"Potentiation of alpha7 nicotinic acetylcholine receptors via an allosteric transmembrane site","volume":"105","author":"Young","year":"2008","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235652400346X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235652400346X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.122.001354","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T13:27:28Z","timestamp":1739971648000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002235652400346X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":61,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S002235652400346X"],"URL":"https:\/\/doi.org\/10.1124\/jpet.122.001354","relation":{},"ISSN":["0022-3565"],"issn-type":[{"type":"print","value":"0022-3565"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differential Activation and Desensitization States Promoted by Noncanonical \u03b1 7 Nicotinic Acetylcholine Receptor Agonists","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.122.001354","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}